Assessment of Disease Activity in Behcet by Complete Blood Count
NCT03747354 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2018-11-20
Summary
* To determine platelet to lymphocyte ratio (PLR), lymphocytes to monocytes ratio (LMR), mean platelet volume (MPV) and neutrophile lymphocyte ratio (NLR), levels in Behçet's disease (BD)
* To investigate their correlation with disease activity.
Conditions
- Behcet Syndrome
Interventions
- DIAGNOSTIC_TEST
-
blood samples
blood samples
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
esraa omar, master · Assiut University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-31
- Primary Completion
- 2019-09-30
- Completion
- 2019-10-31
More Related Trials
-
Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis
NCT05997108 ·Status: UNKNOWN
-
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
NCT06718283 ·Status: RECRUITING
-
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
NCT06730958 ·Status: RECRUITING
-
Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in Egypt
NCT07144514 ·Status: NOT_YET_RECRUITING
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage
NCT05045417 ·Status: UNKNOWN
-
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
NCT04558814 ·Status: UNKNOWN ·Phase: NA
-
Application of MRI for Musculoskeletal Involvement in SLE
NCT04035265 ·Status: UNKNOWN ·Phase: NA
-
Anti-nucleosome B Lymphocytes in Lupus
NCT01889654 ·Status: TERMINATED
-
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
NCT06151990 ·Status: RECRUITING
-
Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
NCT06287125 ·Status: NOT_YET_RECRUITING
-
Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
NCT00029926 ·Status: COMPLETED
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy
NCT02270970 ·Status: UNKNOWN ·Phase: PHASE4
-
Functional MRI in Lupus Nephritis
NCT01731054 ·Status: COMPLETED
-
Urinary Congophilia As an Indicator of Activity of Lupus Nephritis
NCT06654024 ·Status: NOT_YET_RECRUITING
-
"Galectin-3 as a Marker of Subclinical Inflammation in FMF"
NCT06451471 ·Status: COMPLETED
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia
NCT06759519 ·Status: COMPLETED
-
Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
NCT04737343 ·Status: UNKNOWN ·Phase: NA
-
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
NCT02034344 ·Status: COMPLETED
-
Dynamic Imaging of Variation in Lupus Nephritis
NCT03180021 ·Status: COMPLETED
-
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
NCT02922114 ·Status: COMPLETED ·Phase: NA
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
NCT02547922 ·Status: COMPLETED ·Phase: PHASE2